Xenon to Report Q2 2025 Financial Results on August 11, 2025

Core Insights - Xenon Pharmaceuticals Inc. will report its second quarter 2025 financial results and provide a business update on August 11, 2025, after U.S. market close [1] - The company focuses on developing therapeutics for neurological conditions, particularly through its ion channel product portfolio [3] Financial Reporting - The financial results and business update will be available after the close of U.S. financial markets on August 11, 2025 [1] - A live webcast of the presentation will be accessible on the company's website, with a replay available post-event [2] Company Overview - Xenon Pharmaceuticals is dedicated to discovering and developing life-changing therapeutics, with a focus on high unmet medical needs such as epilepsy and depression [3] - The company is advancing Azetukalner, a selective Kv7 potassium channel opener, which is in late-stage clinical development for multiple indications [3]